Marshall Wace, LLP Merrimack Pharmaceuticals Inc Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 38,221 shares of MACK stock, worth $578,283. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,221

Holding current value

$578,283

% of portfolio

0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.68 - $15.13 $561,084 - $578,283	38,221 New	38,221 $578,000
Q2 2023 Aug 14, 2023	SELL	$12.02 - $13.07 $134,840 - $146,619	-11,218 Reduced 11.42%	87,037 $1.07 Million
Q1 2023 May 15, 2023	BUY	$11.35 - $12.32 $1.12 Million - $1.21 Million	98,255 New	98,255 $1.21 Million
Q2 2021 Aug 13, 2021	SELL	$6.04 - $7.77 $317,800 - $408,826	-52,616 Reduced 57.34%	39,150 $250,000
Q1 2021 May 17, 2021	BUY	$6.15 - $8.7 $220,895 - $312,486	35,918 Added 64.31%	91,766 $576,000
Q4 2020 Feb 16, 2021	BUY	$3.69 - $8.31 $206,079 - $464,096	55,848 New	55,848 $385,000

Others Institutions Holding MACK

# of Institutions

Shares Held

429K

Call Options Held

Put Options Held

View Full List

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account